Posts

Showing posts with the label Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market

Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market Focus on Developing New HPV and CMV therapeutics

Image
Human papillomavirus (HPV) is a viral pathogens. It is a different than Herpes Simplex Virus (HSV) and Human Immunodeficiency Virus (HIV). HPV is a major cause of throat, mouth, anus, penis, vagina, vulva, and cervical cancer. Various strains of HPV plays an important role in causing most cervical cancer. Cytomegalovirus (CMV) is also a viral pathogens and is the most common herpesvirus infection. It can spread through both sexual and non-sexual contact with body fluids, such as urine, breast milk, semen, and saliva. Symptoms may include fatigue, diarrhea, fever, hepatitis, pneumonia, shortness of breath, and gastrointestinal ulceration. Growth of the human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market is mainly driven by the increasing number of sexually transmitted infections. According to World Health Organization’s (WHO) 2019 report, each year, more than 290 million women suffer from HPV infection worldwide, and every day, more than one million people suffer f...